Daiwa Securities Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16,799
| Closed | -$3.09M | – | 1359 |
|
|
2021
Q2 | $3.09M | Buy |
16,799
+957
| +6% | +$176K | 0.02% | 338 |
|
|
2021
Q1 | $2.42M | Buy |
15,842
+1,309
| +9% | +$200K | 0.02% | 365 |
|
|
2020
Q4 | $2.27M | Buy |
14,533
+841
| +6% | +$131K | 0.02% | 355 |
|
|
2020
Q3 | $1.57M | Buy |
13,692
+2,249
| +20% | +$257K | 0.01% | 393 |
|
|
2020
Q2 | $1.03M | Hold |
11,443
| – | – | 0.02% | 351 |
|
|
2020
Q1 | $1.03M | Buy |
11,443
+294
| +3% | +$26.4K | 0.01% | 458 |
|
|
2019
Q4 | $1.21M | Sell |
11,149
-1,980
| -15% | -$214K | 0.01% | 473 |
|
|
2019
Q3 | $1.29M | Buy |
13,129
+1,569
| +14% | +$154K | 0.01% | 443 |
|
|
2019
Q2 | $1.51M | Sell |
11,560
-510
| -4% | -$66.8K | 0.01% | 398 |
|
|
2019
Q1 | $1.63M | Buy |
12,070
+2,029
| +20% | +$274K | 0.01% | 379 |
|
|
2018
Q4 | $978K | Buy |
10,041
+710
| +8% | +$69.2K | 0.01% | 453 |
|
|
2018
Q3 | $1.3M | Buy |
9,331
+657
| +8% | +$91.3K | 0.01% | 450 |
|
|
2018
Q2 | $1.08M | Buy |
8,674
+200
| +2% | +$24.8K | 0.01% | 478 |
|
|
2018
Q1 | $945K | Buy |
8,474
+1,848
| +28% | +$206K | 0.01% | 504 |
|
|
2017
Q4 | $792K | Buy |
6,626
+44
| +0.7% | +$5.26K | 0.01% | 533 |
|
|
2017
Q3 | $923K | Buy |
6,582
+282
| +4% | +$39.5K | 0.01% | 467 |
|
|
2017
Q2 | $767K | Buy |
6,300
+200
| +3% | +$24.3K | 0.01% | 484 |
|
|
2017
Q1 | $740K | Buy |
6,100
+200
| +3% | +$24.3K | ﹤0.01% | 508 |
|
|
2016
Q4 | $722K | Buy |
5,900
+400
| +7% | +$48.9K | ﹤0.01% | 469 |
|
|
2016
Q3 | $674K | Hold |
5,500
| – | – | ﹤0.01% | 464 |
|
|
2016
Q2 | $642K | Buy |
5,500
+200
| +4% | +$23.3K | ﹤0.01% | 457 |
|
|
2016
Q1 | $738K | Buy |
5,300
+200
| +4% | +$27.8K | ﹤0.01% | 433 |
|
|
2015
Q4 | $973K | Buy |
5,100
+100
| +2% | +$19.1K | 0.01% | 360 |
|
|
2015
Q3 | $782K | Buy |
5,000
+500
| +11% | +$78.2K | 0.01% | 398 |
|
|
2015
Q2 | $813K | Sell |
4,500
-100
| -2% | -$18.1K | 0.01% | 428 |
|
|
2015
Q1 | $797K | Sell |
4,600
-100
| -2% | -$17.3K | 0.01% | 376 |
|
|
2014
Q4 | $870K | Sell |
4,700
-300
| -6% | -$55.5K | 0.01% | 337 |
|
|
2014
Q3 | $829K | Sell |
5,000
-300
| -6% | -$49.7K | 0.01% | 318 |
|
|
2014
Q2 | $828K | Hold |
5,300
| – | – | 0.01% | 321 |
|
|
2014
Q1 | $806K | Sell |
5,300
-400
| -7% | -$60.8K | 0.01% | 315 |
|
|
2013
Q4 | $757K | Sell |
5,700
-400
| -7% | -$53.1K | 0.01% | 307 |
|
|
2013
Q3 | $709K | Sell |
6,100
-200
| -3% | -$23.2K | 0.01% | 322 |
|
|
2013
Q2 | $581K | Buy |
+6,300
| New | +$581K | ﹤0.01% | 383 |
|